Sympathetic overactivity in renal disease: A window to understand progression and cardiovascular complications of uraemia?

Nephrology Dialysis Transplantation

Volumn 15, Issue 11, 2000, Pages 1735-1738

  Rump, Lars Christian ^a   Amann, Kerstin ^b   Orth, Stephan ^c   Ritz, Eberhard ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Chronic renal failure; Hypertension; Sympathetic nervous system

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; ANGIOTENSIN; BETA 1 ADRENERGIC RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GROWTH FACTOR; IMIDAZOLINE; IMIDAZOLINE I1 RECEPTOR; MOXONIDINE; NEUROPEPTIDE Y; PLATELET DERIVED GROWTH FACTOR; RENIN; TRANSFORMING GROWTH FACTOR BETA;

ADRENERGIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; HUMAN; NEPHRECTOMY; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; RENOVASCULAR HYPERTENSION; SYMPATHETIC INNERVATION; SYMPATHETIC TONE; UREMIA; VASOMOTOR REFLEX;

EID: 0033760176     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.11.1735     Document Type: Article

References (27)

1. End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions
2. Hypertension in the ESRD patient: Pathophysiology, therapy, outcomes, and future directions
3. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials
4. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis
5. Sympathetic overactivity in patients with chronic renal failure
6. Neurogenic factors and hypertension in chronic renal failure
7. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure
8. Muscle sympathetic nerve activity in renal allograft recipients and in hemodialysis
9. A limited renal injury may cause a permanent form of neurogenic hypertension
10. The relationship between the sympathetic nervous system and the reninangiotensin system in renovascular hypertension
11. Increased sympathetic nerve activity in renovascular hypertension
12. Increased norepinephrine secretion in patients with the nephrotic syndrome and normal glomerular filtration rates: Evidence for primary sympathetic activation
13. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives
14. Uremic autonomic neuropathy studied by spectral analysis of heart rate
15. Autonomic dysregulation in patients awaiting kidney transplantation
16. Acetycholine release in human atria: Influence of muscarinic autoreceptors, age and diabetes
17. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomised rats
18. Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters
19. Isoproterenol stimulates tubular DNA replication in mice
20. Sympathetic neurotransmitters ATP, neuropeptide and noradrenaline induce proliferation of human visceral glomerular epithelial cells
21. 2 inhibits noradrenaline release and purinergic pressor responses to renal nerve stimulation at 1 Hz in isolated kidneys of young spontaneously hypertensive rats
22. Extracellular ATPin the human kidney: Mode of release and vascular effects
23. Effect of ramipiril, nifedipine and moxonidine on glomerular morphology and podocyte structure in expiremental renal failure
24. Effects of imidazolines on noradrenaline release in rat isolated kidney
25. Central imidazoline (I1) receptors as targets of centrally acting antihypertensives: Moxonidine and rilmenidine
26. Moxonidine inhibits Na+/H+ exchange in proximal tubule cells and cortical collecting duct
27. Plasma catecholamines and autonomic nervous system function in patients with early renal insufficiency and hypertension: Effect of clonidine